Corsello SM, Roti G, Ross KN, et al. Identification of AML1-ETO modulators by chemical genomics. Blood. 2009;113(24):6193-205. doi:10.1182/blood-2008-07-166090
Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673-7. doi:10.1038/ng2003
Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-8. doi:10.1038/nature03702
Ebert BL, Lee MM, Pretz JL, et al. An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood. 2005;105(12):4620-6. doi:10.1182/blood-2004-08-3313
Du J, Widlund HR, Horstmann MA, et al. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell. 2004;6(6):565-76. doi:10.1016/j.ccr.2004.10.014
Golub TR. Toward a functional taxonomy of cancer. Cancer Cell. 2004;6(2):107-8. doi:10.1016/j.ccr.2004.08.007
Carter SL, Cibulskis K, Helman E, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30(5):413-21. doi:10.1038/nbt.2203
Ho HJ, Lin TI, Chang HH, Haase SB, Huang S, Pyne S. Parametric modeling of cellular state transitions as measured with flow cytometry. BMC Bioinformatics. 2012;13 Suppl 5:S5. doi:10.1186/1471-2105-13-S5-S5
Jalili A, Wagner C, Pashenkov M, et al. Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma. J Natl Cancer Inst. 2012;104(21):1673-9. doi:10.1093/jnci/djs373
Gardet A, Benita Y, Li C, et al. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol. 2010;185(9):5577-85. doi:10.4049/jimmunol.1000548